68141-00-4

Usage

Uses

Used in Water Treatment and Metal Finishing Industry:
(2-hydroxyethyl)ammonium hydroxyacetate is used as a corrosion inhibitor for protecting metal surfaces from corrosion and promoting the longevity of equipment and infrastructure.
Used in Pharmaceutical and Cosmetic Products:
(2-hydroxyethyl)ammonium hydroxyacetate is used as a buffering agent to maintain a stable pH level, ensuring the efficacy and safety of pharmaceutical and cosmetic formulations.
Used in the Synthesis of Metal-Organic Frameworks:
(2-hydroxyethyl)ammonium hydroxyacetate is studied for its potential applications in the synthesis of metal-organic frameworks, which have promising uses in gas storage, catalysis, and drug delivery.
Used as a Catalyst in Organic Reactions:
(2-hydroxyethyl)ammonium hydroxyacetate is also being explored for its potential as a catalyst in various organic reactions, contributing to the development of new chemical processes and products.

InChI:InChI=1/C2H7NO.C2H4O3/c3-1-2-4;3-1-2(4)5/h4H,1-3H2;3H,1H2,(H,4,5)

Upstream product

• 79-14-1 glycolic Acid 
• 141-43-5 ethanolamine 

Relevant academic research and scientific papers

Cytotoxicity of protic ionic liquids towards the HaCat cell line derived from human skin

In this work we have investigated the toxicity of 10 PILs, consisting of ethyl-, ethanol-, diethanol- and triethanolammonium cations paired with nitrate, formate, acetate and glycolate anions. Their toxicity was quantified by the EC50 values of each of these PILs towards HaCat cells, which are derived from human skin cells. Additional salts and solvents were used for comparison including DMSO, choline chloride, potassium nitrate, sodium acetate and ethanol to distinguish if the toxicity changes were due to ionicity, short chain amphiphilic behaviour, or specific ion effects. The toxicity followed the general trend of choline chloride acetate containing PILs DMSO sodium acetate ethanol nitrate containing PILs or salt. Ethanolammonium acetate and ethylammonium acetate were identified as having the lowest toxicities of the PILs, being slightly more toxic than choline chloride or DMSO. Overall the toxicity was found to be highly dependent on the cation and anion combination, with the anion having a stronger affect. It was evident that the PILs can be tailored to vary their toxicities, and this is expected to be dependent on which cell lines are used.

The hydrophilic ionic liquid at room temperature and its use

PROBLEM TO BE SOLVED: To provide a novel ionic liquid that is liquid at a room temperature and is hydrophilic, particularly water-soluble, and use thereof.SOLUTION: This invention provides a hydrophilic room-temperature ionic liquid including a cation and an anion, the cation being a quaternary ammonium cation of the formula (I), and the anion being a carboxylate anion, where R represents a 1-5C straight-chain or branched-chain alkylene group, and n represents an integer of 1-3.

Compositions and method for promoting the growth of human hair

Provided are compositions comprising monoethanolamine salts of thioglycolic, salicylic, lactic and glycolic acids in combination with an organic enzyme, preferably papain, and an oxidizing aged their methods of use to induce hair growth in the scalp of hu

Treatment of skin keratoses with α-hydroxy acids and related compounds

Preventive as well as therapeutic treatment to alleviate the symptoms of skin keratoses consisting of topical application of a solution, gel, lotion, cream or ointment containing one or more of the α- or β-hydroxy acids or α-keto acids, esters thereof, and their amine salts is disclosed. The compounds include free acid or amine salt forms of α-hydroxy-butyric acid, α-hydroxyisobutyric acid, α-hydroxyisocaproic acid, α-hydroxyisovaleric, atrolactic acid, β-hydroxybutyric acid, β-phenyl lactic acid, β-phenylpyruvic acid, citric acid, ethyl pyruvate, galacturonic acid, glucoheptonic acid, glucoheptono 1,4-lactone, gluconic acid, gluconolactone, glucuronic acid, glucuronolactone, glycolic acid, isopropyl pyruvate, lactic acid, malic acid, mandelic acid, methyl pyruvate, mucic acid, pyruvic acid, saccharic acid, saccharic acid 1,4-lactone, tartaric acid, and tartronic acid. The therapeutic composition may include one or more of the compounds present in the total amount of from three to thirty percent. Topical application to affected areas has been found to achieve from substantial to complete remissions of the keratoses in humans.